secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIRA PHARMACEUTICALS, INC. (MIRA)
CIK:        0001904286
Form:       8-K
Filed at:   2026-09-16T20:30:24+00:00
Accession:  0001493152-26-042927
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MIRA shareholders elect five directors and ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- At Sept 11, 2026 annual meeting, 26,499,076 shares voted (63.06% quorum); five directors elected.
- Erez Aminov, Matthew Whalen, Matthew Del Giudice, Denil Shekhat, Edward MacPherson elected with ~20.1-20.6M votes each.
- Ratification of Salberg & Company as auditor for FY2026 passed: 25,950,852 for, 158,064 against, 390,160 abstain.
- Adjournment proposal approved: 24,897,741 for, 1,205,307 against, 396,028 abstain.
- Record date was July 21, 2026; 42,022,087 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1904286/000149315226042927/0001493152-26-042927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1904286/000149315226042927/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer